• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.儿童转移性尤文肉瘤患者肺部转移灶快速完全缓解的生存结果。
Pediatr Blood Cancer. 2024 Jul;71(7):e31026. doi: 10.1002/pbc.31026. Epub 2024 Apr 28.
2
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma.大剂量化疗后自体造血干细胞移植治疗原发性转移性尤文肉瘤的儿童、青少年和年轻成人。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD011405. doi: 10.1002/14651858.CD011405.pub2.
3
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.诱导后肺部病变缓解对转移性尤文肉瘤的临床影响。
Pediatr Blood Cancer. 2020 Apr;67(4):e28150. doi: 10.1002/pbc.28150. Epub 2020 Jan 15.
6
Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.全肺照射对肺复发尤文肉瘤患者生存结局的影响。
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):584-592. doi: 10.1016/j.ijrobp.2018.06.032. Epub 2018 Jul 3.
7
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.
8
Do Patients of Different Levels of Affluence Receive Different Care for Pediatric Osteosarcomas? One Institution's Experience.不同富裕程度的患者在小儿骨肉瘤治疗上是否得到不同的护理?一家机构的经验。
Clin Orthop Relat Res. 2025 Apr 1;483(4):748-758. doi: 10.1097/CORR.0000000000003299. Epub 2024 Oct 30.
9
Can We Accurately Predict Adult Height in Pediatric Patients Who Undergo Treatment for Sarcoma?我们能否准确预测接受肉瘤治疗的儿科患者的成人身高?
Clin Orthop Relat Res. 2025 Feb 6;483(7):1338-46. doi: 10.1097/CORR.0000000000003409.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

引用本文的文献

1
Consensus recommendations regarding local and metastasis-directed therapies in the management of relapsed/recurrent Ewing sarcoma.关于复发性/转移性尤因肉瘤治疗中局部和转移导向治疗的共识性建议。
Cancer. 2025 May 1;131(9):e35858. doi: 10.1002/cncr.35858.

本文引用的文献

1
Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.诱导后肺部病变缓解对转移性尤文肉瘤的临床影响。
Pediatr Blood Cancer. 2020 Apr;67(4):e28150. doi: 10.1002/pbc.28150. Epub 2020 Jan 15.
2
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.高剂量化疗与标准化疗和肺放疗联合治疗伴肺转移尤文肉瘤的疗效比较:来自欧洲尤文肿瘤国家协作组 99 试验和 EWING2008 试验的结果。
J Clin Oncol. 2019 Dec 1;37(34):3192-3202. doi: 10.1200/JCO.19.00915. Epub 2019 Sep 25.
3
Ewing sarcoma.尤因肉瘤。
Nat Rev Dis Primers. 2018 Jul 5;4(1):5. doi: 10.1038/s41572-018-0003-x.
4
Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas.横纹肌肉瘤、尤文肉瘤和其他小圆细胞肉瘤。
J Clin Oncol. 2018 Jan 10;36(2):168-179. doi: 10.1200/JCO.2017.74.7402. Epub 2017 Dec 8.
5
Management and follow-up of Ewing sarcoma patients with isolated lung metastases.孤立性肺转移的尤因肉瘤患者的管理与随访
J Pediatr Surg. 2016 Jul;51(7):1067-71. doi: 10.1016/j.jpedsurg.2015.11.012. Epub 2015 Nov 24.
6
Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.接受化疗和R0切除治疗的尤因肉瘤患者的预后因素及复发模式
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):349-57. doi: 10.1016/j.ijrobp.2015.01.022. Epub 2015 Mar 12.
7
Survival following Pulmonary Metastasectomy for Sarcoma.肉瘤肺转移瘤切除术后的生存情况。
Thorac Cardiovasc Surg. 2016 Mar;64(2):146-9. doi: 10.1055/s-0035-1546430. Epub 2015 Mar 5.
8
Risk stratification for wilms tumor: current approach and future directions.肾母细胞瘤的风险分层:当前方法与未来方向。
Am Soc Clin Oncol Educ Book. 2014:215-23. doi: 10.14694/EdBook_AM.2014.34.215.
9
Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.基于风险的肺放疗在儿童 IV 期肾母细胞瘤肺转移治疗中的应用。
J Clin Oncol. 2012 Oct 1;30(28):3533-9. doi: 10.1200/JCO.2011.35.8747. Epub 2012 Aug 27.
10
Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH.肿瘤生物学影响伴有原发性肺转移的肾母细胞瘤患者的预后:SIOP 93-01/GPOH 和 SIOP 2001/GPOH 的结果。
Ann Surg. 2011 Jul;254(1):155-62. doi: 10.1097/SLA.0b013e318222015e.

儿童转移性尤文肉瘤患者肺部转移灶快速完全缓解的生存结果。

Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.

机构信息

Division of Pediatric Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Northwestern Quality Improvement, Research, and Education in Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

Pediatr Blood Cancer. 2024 Jul;71(7):e31026. doi: 10.1002/pbc.31026. Epub 2024 Apr 28.

DOI:10.1002/pbc.31026
PMID:38679864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11116042/
Abstract

PURPOSE

Our objectives were to compare overall survival (OS) and pulmonary relapse between patients with metastatic Ewing sarcoma (EWS) at diagnosis who achieve rapid complete response (RCR) and those with residual pulmonary nodules after induction chemotherapy (non-RCR).

PATIENTS AND METHODS

This retrospective cohort study included children under 20 years with metastatic EWS treated from 2007 to 2020 at 19 institutions in the Pediatric Surgical Oncology Research Collaborative. Chi-square tests were conducted for differences among groups. Kaplan-Meier curves were generated for OS and pulmonary relapse.

RESULTS

Among 148 patients with metastatic EWS at diagnosis, 61 (41.2%) achieved RCR. Five-year OS was 71.2% for patients who achieved RCR, and 50.2% for those without RCR (p = .04), and in multivariable regression among patients with isolated pulmonary metastases, RCR (hazards ratio [HR] 0.42; 95% confidence interval [CI]: 0.17-0.99) and whole lung irradiation (WLI) (HR 0.35; 95% CI: 0.16-0.77) were associated with improved survival. Pulmonary relapse occurred in 57 (37%) patients, including 18 (29%) in the RCR and 36 (41%) in the non-RCR groups (p = .14). Five-year pulmonary relapse rates did not significantly differ based on RCR (33.0%) versus non-RCR (47.0%, p = .13), or WLI (38.8%) versus no WLI (46.0%, p = .32).

DISCUSSION

Patients with EWS who had isolated pulmonary metastases at diagnosis had improved OS if they achieved RCR and received WLI, despite having no significant differences in rates of pulmonary relapse.

摘要

目的

本研究旨在比较初诊时发生转移的尤文肉瘤(EWS)患者中,达到快速完全缓解(RCR)的患者与诱导化疗后仍存在肺部残留结节(非 RCR)患者的总生存期(OS)和肺部复发情况。

患者和方法

本回顾性队列研究纳入了 2007 年至 2020 年期间在小儿外科学肿瘤协作研究机构的 19 家机构接受治疗的 20 岁以下发生转移的 EWS 患儿。采用卡方检验比较各组间的差异。绘制 OS 和肺部复发的 Kaplan-Meier 曲线。

结果

在初诊时发生转移的 148 例 EWS 患者中,61 例(41.2%)达到 RCR。达到 RCR 的患者 5 年 OS 为 71.2%,未达到 RCR 的患者为 50.2%(p=0.04)。在单纯肺部转移的患者中,多变量回归分析显示,RCR(风险比 [HR] 0.42;95%置信区间 [CI]:0.17-0.99)和全肺照射(WLI)(HR 0.35;95% CI:0.16-0.77)与生存改善相关。57 例(37%)患者发生肺部复发,其中 RCR 组 18 例(29%),非 RCR 组 36 例(41%)(p=0.14)。基于 RCR(33.0%对非 RCR(47.0%),p=0.13)或 WLI(38.8%对无 WLI(46.0%),两组患者的 5 年肺部复发率无显著差异(p=0.32)。

讨论

初诊时发生孤立性肺部转移的 EWS 患者,如果达到 RCR 并接受 WLI,其 OS 会得到改善,尽管肺部复发率无显著差异。